Funding for this research was provided by:
NIH (U19AG069701, RF1AG071226, RF1AG068034, RF1AG057181)
Cure Alzheimer's Fund
Florida Department of Health Ed and Ethel Moore Alzheimer’s Disease Research Program (22A08)
Article History
Received: 2 February 2023
Accepted: 28 June 2023
First Online: 11 July 2023
Declarations
:
: Not applicable.
: All authors agreed to publish.
: G.B. is an employee of SciNeuro Pharmaceuticals. Other authors declare no competing interests.